UnknownPhase 4NCT01111994

Efficacy & Safety of Clindamycin and Tretinoin in Acne

Studying Anterior cutaneous nerve entrapment syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Callender Center for Clinical Research
Principal Investigator
Valerie Callender, MD
Callender Center for Clinical Research
Intervention
Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel(drug)
Enrollment
30 enrolled
Eligibility
12 years · All sexes
Timeline
20092010

Study locations (2)

Collaborators

Society Hill Dermatology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01111994 on ClinicalTrials.gov

Other trials for Anterior cutaneous nerve entrapment syndrome

Additional recruiting or active studies for the same condition.

See all trials for Anterior cutaneous nerve entrapment syndrome

← Back to all trials